Harrington Discovery Institute is a Cleveland-based nonprofit, foundation-backed capital provider for translational life sciences and therapeutics programs. It funds and supports drug-development paths through programs such as ADDF-Harrington, Gund Harrington, Brain Health Medicines, Harrington Rare Disease and Oxford-Harrington, with an investment advisory board managing philanthropic and impact investments in scholar technologies. It is most relevant to academic founders and biotech or pharmaceutical companies raising early-stage capital in life sciences, biotechnology, pharmaceuticals, HealthTech and oncology, with activity across the United States and United Kingdom.